Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4399 USD | +2.37% | +18.89% | -77.44% |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-77.44% | 2.95M | |
-2.67% | 102B | |
+2.02% | 96.29B | |
+1.86% | 22.18B | |
-15.33% | 21.2B | |
-8.77% | 18.31B | |
-39.98% | 17.38B | |
-14.17% | 16.36B | |
+5.55% | 13.97B | |
+32.97% | 12.17B |
- Stock Market
- Equities
- AGRX Stock
- News Agile Therapeutics, Inc.
- Agile Therapeutics' : Price Target Trimmed to $5 From $6 by RBC on Equity Dilution; Outperform, Speculative Risk Maintained